Clinical Trials Directory

Trials / Sponsors / Sarfez Pharmaceuticals, Inc.

Sarfez Pharmaceuticals, Inc.

Industry · 11 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release
Hypertension (HTN)
Phase 32025-12-01
CompletedBioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects
Bioequivalence Study in Healthy Subjects, PK/PD
Phase 32025-07-01
CompletedA Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide
Bioavailability Heathy Volunteers
Phase 32025-06-15
CompletedBioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone
Bioavailability Heathy Volunteers
Phase 32025-06-15
CompletedComparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure
Heart Failure, Edema, Pulmonary Congestion
Phase 42025-05-28
TerminatedA Crossover Study of Patients with HF to Compare Natriuretic Effects of IR Torsemide Vs. ER Torsemide Over 12
Heart Failure
Phase 42025-01-15
TerminatedImmediate Release Torsemide Versus Extended Release Torsemide After Salty Meal
Heart Failure
Phase 22024-11-15
CompletedEffect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder
Heart Failure, Overactive Bladder, Incontinence
Phase 22024-06-15
CompletedComparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide
Body Weight Changes
Phase 12021-06-30
CompletedA Food Effect Study of 60mg ER Torsemide
Food-drug Interaction
Phase 12017-10-17
CompletedWithin Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects
Congestive Heart Failure, Chronic Kidney Diseases
Phase 12017-06-19